How much revenue did Sanofi generate this year?
Sanofi has achieved a revenue of 47.51 B EUR this year.
Sanofi Revenue 2024
Sanofi Revenue
47.51 B EUR
Sanofi Dividend yield
4.01 %
Ticker
SAN.PA
ISIN
FR0000120578
WKN
920657
In 2024, Sanofi's sales reached 47.51 B EUR, a 2.3% difference from the 46.44 B EUR sales recorded in the previous year.
The Sanofi Revenue history
| YEAR | REVENUE (undefined EUR) | GROSS MARGIN (%) |
|---|---|---|
| 2029e | 58.02 | 55,51 |
| 2028e | 56.59 | 56,91 |
| 2027e | 56.08 | 57,43 |
| 2026e | 53.27 | 60,47 |
| 2025e | 50.86 | 63,32 |
| 2024e | 47.51 | 67,79 |
| 2023 | 46.44 | 69,35 |
| 2022 | 45.39 | 69,83 |
| 2021 | 39.18 | 68,72 |
| 2020 | 37.37 | 67,46 |
| 2019 | 37.63 | 68,17 |
| 2018 | 35.68 | 67,95 |
| 2017 | 36.22 | 67,94 |
| 2016 | 34.7 | 69,16 |
| 2015 | 34.86 | 68,68 |
| 2014 | 32 | 68,03 |
| 2013 | 31.29 | 67,08 |
| 2012 | 35.96 | 69,14 |
| 2011 | 35.06 | 68,90 |
| 2010 | 34.04 | 72,39 |
| 2009 | 31.23 | 74,04 |
| 2008 | 28.82 | 74,54 |
| 2007 | 29.21 | 74,08 |
| 2006 | 29.49 | 74,27 |
| 2005 | 28.51 | 73,46 |
| 2004 | 15.73 | 71,79 |
Sanofi Aktienanalyse
What does Sanofi do?
Sanofi SA is a French company that was formed in 1973 from a merger of two French pharmaceutical and biotechnology companies. It is one of the largest players in the healthcare industry worldwide and employs over 100,000 employees. The objective of Sanofi is to improve people's lives through innovative medicines and therapies. In this regard, the company pursues a comprehensive business model that focuses on both research and development, as well as the production and distribution of medications and vaccines. The company has different divisions and product lines, which are divided into three business areas: Innovative Medicine, Consumer Healthcare, and Generic Pharmaceuticals. Innovative Medicine utilizes state-of-the-art technologies and scientific knowledge to treat the most challenging diseases. In the area of Consumer Healthcare, the company offers a wide range of over-the-counter products such as vitamins, dietary supplements, cough and cold remedies, as well as oral and dental health products. In the Generic Pharmaceuticals field, the company produces more cost-effective alternatives to expensive brand-name products, providing a variety of generic medications. Sanofi is a leading manufacturer of medications that are of great significance in various areas such as diabetes, oncology, cardiovascular diseases, and neurology. In recent years, the company has also established a strong presence in the field of vaccines. Here, Sanofi develops and produces innovative vaccines against COVID-19, influenza, and other infectious diseases. Sanofi is present in more than 170 countries and collaborates closely with physicians, research institutions, and health authorities to improve healthcare worldwide. The company conducts research and development in various disciplines and invests a significant amount each year in the development of innovative medicines and therapies. Overall, Sanofi SA is an emerging company in the pharmaceutical and healthcare sector. The portfolio of products and therapies offered by Sanofi is extensive and covers many areas of healthcare. Sanofi relies on continuous innovation and continuously works to improve healthcare and enhance the lives of people worldwide. Sanofi ist eines der beliebtesten Unternehmen auf Eulerpool.com.Revenue Details
Understanding Sanofi's Sales Figures
The sales figures of Sanofi originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.
Year-to-Year Comparison
Analyzing Sanofi’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.
Impact on Investments
Investors often scrutinize Sanofi's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.
Interpreting Sales Fluctuations
Increases in Sanofi’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.
Frequently Asked Questions about Sanofi Stock
How much was the turnover of the company Sanofi compared to the previous year?
The revenue of Sanofi has increased by 2.3% increased compared to the previous year.
What does revenue mean for investors?
The revenue of a company is an important indicator of its financial performance and attractiveness for investors.
Which factors influence the revenue of Sanofi?
The revenue of Sanofi is influenced by various factors, including the demand for its products and services, market conditions, and prices.
How is the revenue of Sanofi measured?
Revenue is typically measured in units referring to the sale of goods and services provided by the company.
How does an increase in sales affect investments?
An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.
What are the possible risks associated with a declining revenue?
A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.
Why is the sales revenue of Sanofi so important for investors?
The revenue of Sanofi is an important indicator of financial performance and attractiveness for investors.
What strategic measures can a company take to increase revenue?
A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.
How much dividend does Sanofi pay?
Over the past 12 months, Sanofi paid a dividend of 3.56 EUR . This corresponds to a dividend yield of about 4.01 %. For the coming 12 months, Sanofi is expected to pay a dividend of 3.76 EUR.
What is the dividend yield of Sanofi?
The current dividend yield of Sanofi is 4.01 %.
When does Sanofi pay dividends?
Sanofi pays a quarterly dividend. This is distributed in the months of June, June, June, June.
How secure is the dividend of Sanofi?
Sanofi paid dividends every year for the past 26 years.
What is the dividend of Sanofi?
For the upcoming 12 months, dividends amounting to 3.76 EUR are expected. This corresponds to a dividend yield of 4.23 %.
In which sector is Sanofi located?
Sanofi is assigned to the 'Health' sector.
Wann musste ich die Aktien von Sanofi kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Sanofi from 5/15/2024 amounting to 3.76 EUR, you needed to have the stock in your portfolio before the ex-date on 5/13/2024.
When did Sanofi pay the last dividend?
The last dividend was paid out on 5/15/2024.
What was the dividend of Sanofi in the year 2023?
In the year 2023, Sanofi distributed 3.313 EUR as dividends.
In which currency does Sanofi pay out the dividend?
The dividends of Sanofi are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Sanofi stock can be added to a savings plan with the following providers: Trade Republic, Scalable Capital and Consorsbank
Andere Kennzahlen von Sanofi
Our stock analysis for Sanofi Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Sanofi Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
